Bill Corl Strengthens Cannabix Technologies Board
Vancouver, Canada - Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) is excited to announce the addition of William (Bill) R. Corl to its board of directors. With over twenty-six years in technology management across various sectors, Mr. Corl is presently the Chief Executive Officer at Omega Laboratories, a recognized leader in specimen drug testing.
A Synergistic Partnership
Kicking off their collaboration in mid-2024, Cannabix and Omega Laboratories embarked on a strategic partnership aimed at enhancing the commercialization of Cannabix’s Marijuana Breath Test (MBT) technology. This alliance marks a significant milestone in advancing drug screening methodologies.
Bill Corl’s Distinguished Background
Mr. Corl’s extensive experience spans diagnostic testing, media, and radiology. His passion for the drug testing industry is evident through his initiatives advocating for the regulatory approval of innovative drug testing methods including hair and oral fluid testing for substance abuse. Notably, he chaired standards panels for drug testing in the global oil and gas sector and has advised international bodies including the United Nations Office of Drugs and Crime.
A Leader in Forensic Testing
Omega Laboratories stands out in the field of forensic drug testing and has built a reputation over more than two decades for its advanced capabilities. Their Ohio-based facility boasts multiple certifications and is known for adopting cutting-edge technologies to provide accurate tests for drugs of abuse.
Advancements in Marijuana Breath Testing
The collaboration between Cannabix and Omega is now focused on swiftly launching the Marijuana Breath Test (MBT) to key clients. This innovative technology aims to set a new standard in on-site testing for recent marijuana use. Recognizing the growing need for effective drug screening, Omega has already integrated Cannabix Breath Cartridges into its service offerings.
Comprehensive Support and Distribution
In addition to product integration, both companies are working on strategies for marketing, distribution, and customer support related to the MBT, ensuring that they can meet the increasing demand for accurate drug testing solutions in various environments.
About Cannabix Technologies
Cannabix Technologies Inc. is at the forefront of developing innovative breath testing technologies targeting both marijuana and alcohol detection. Their focus on delta-9 THC breath testing represents a significant step forward in workplace and law enforcement drug screening methods. Moreover, Cannabix is proud to be the creator of the BreathLogix sensor, aimed at enhancing alcohol monitoring in organizations committed to safety.
For further inquiries, please contact the Company at info@cannabixtechnologies.com.
Frequently Asked Questions
Who is Bill Corl?
Bill Corl is the CEO of Omega Laboratories and has joined the board of Cannabix Technologies, bringing extensive experience in drug testing technologies.
What is Cannabix Technologies known for?
Cannabix Technologies specializes in developing breath testing technologies for detecting marijuana and alcohol consumption.
What is the significance of the partnership with Omega Laboratories?
The partnership aims to enhance the commercialization of Cannabix's Marijuana Breath Test technology, leveraging Omega's expertise in drug testing.
How long has Omega Laboratories been operational?
Omega Laboratories has been a leading provider of forensic drug testing for over twenty years.
What is the goal of the Marijuana Breath Test?
The goal of the Marijuana Breath Test is to provide accurate and timely testing for recent marijuana use, supporting various industries including law enforcement.
